Inhibikase Therapeutics, Inc. (IKT) — research page
US · us-cm-kg/NASDAQ/IKT · as of 2026-11-08
Identity and listing
Inhibikase Therapeutics, Inc. is listed on NASDAQ under the ticker IKT. Its ISIN is US45719W2052 and its LEI is 549300066CFEWOA17F12. Its security type is Corporate and its sector is 2836 Biological Products, (No Diagnostic Substances). Its segment is not on the record. Its jurisdiction is United States, Delaware. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Inhibikase Therapeutics, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | IKT | source · 2026-11-08 |
| ISIN | US45719W2052 | source · 2026-10-09 |
| LEI | 549300066CFEWOA17F12 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 62 filings across 31 filing days in the twelve months to 2026-11-08. The median gap between filing days is 7.0 days. The latest filing is dated 2026-10-21 and is of type directors_dealings, 18 days before the record date. The NASDAQ median is 6.0 days for cadence, 52 filings and 5.0 days for latency across 4,359 issuers. The 2836 Biological Products, (No Diagnostic Substances) sector median is 5.5 days for cadence, 65.5 filings and 4.0 days for latency across 176 issuers. Filings by type are ad_hoc 1, agm_egm 3, corporate_news 7, director_change 3, directors_dealings 18, prospectus 3, regulatory_filing 19 and results 8.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 62 | 7 | 18 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-21 | directors_dealings | 4 | 4 — 4 |
| 2026-10-21 | directors_dealings | 3 | 3 — 3 |
| 2026-10-20 | director_change | 8-K | 8-K — 8-K (items 5.02,7.01,9.01) |
| 2026-09-08 | corporate_news | 8-K | 8-K — 8-K (items 7.01,9.01) |
| 2026-08-26 | director_change | 8-K | 8-K — 8-K (items 4.01,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag, and the auditor's location is not on the record. The record holds one auditor change, dated 2026-08-26.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed annual years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The earliest sealed date of the US market is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001750149.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/IKT (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/IKT (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US45719W2052"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:14e5f2d6f47f854f.